Jun. 10 at 2:38 PM
$BDSX just dropped a major update:
They’ve officially launched the first nationwide medical education program in the U.S.
Combining this with their diagnostic platform, it looks like they’re aiming for revenue diversification and potential policy tailwinds.
Interesting move for anyone watching biotech plays.
As for
$KLTO –
Only 3 employees and a heavy debt load.
I took the recent bounce as an opportunity to lock in profits.
Also keeping an eye on:
$NCNA – oncology pipeline could get traction with upcoming catalysts
$CARM – watching for progress on their cell therapy programs
⚠️ Not financial advice, just sharing what I'm tracking.
Do your own DD and manage risk accordingly. Stay safe out there 🙏
